GENE THERAPY VECTOR

CLINICAL CENTER GENOTYPING CENTER
Information regarding Cystic Fibrosis, the types of research being performed to finds its cure.  Learn more about gene therapy, and treatments for Cystic Fibrosis as well as volunteering opportunities.
The Center has many research laboratories dedicated to finding a cure for Cystic Fibrosis.  Meet the different lab directors, their lab members and the laboratories particular focus.
A complete list of publications from the Centers lab directors that are related to Cystic Fibrosis.
Apply for open positions at the Cystic Fibrosis Research Development Center.
Visit other websites of organizations and associations affiliated with Cystic Fibrosis.
Letter from the Director addressing the Centers continued plan for the future.
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

 

 

Beth L. Laube

Beth Home|Publications|Lab Members 

 

 

Beth L. Laube

Associate Professor
The Johns Hopkins University School of Medicine
Department of Pediatrics
Division of Pediatric Pulmonary
Baltimore, MD
600 North Wolfe Street
Baltimore, Maryland 21287-2533

blaube@jhmi.edu 

 

Beth Laube

       
  Publications
 

Suman, J., Laube, B.L., Dalby, R.N.  Nasal nebulizers versus aqueous nasal pumps: a comparison of deposition in human volunteers.  In: Dalby, R.N., Byron, P.R., and Farr, S. J., eds.  Respiratory Drug Delivery VI.  Buffalo Grove, IL.  Interpharm Press, Inc. (1998), pp 211-218.

 

Laube, B.L., Benedict, G.W., Dobs, A. S.  The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes.  Chest 114:1734-1739, 1998.

 
Suman, J., Laube, B.L. Dalby, R.N.  Comparison of nasal deposition and clearance of aerosol generated by a nebulizer and an aqueous spray pump.  Pharm. Res. 16:1648-1652, 1999.
 

Kesavanathan, J., Bascom, R., Laube, B., Swift, D.L.  The relationship between particle deposition in the anterior nasal passage and nasal passage characteristics.  J. Aerosol Med. 13: 17-23, 2000.

 

Suman, J., Laube, B.L., Lin, T-C., Guillaume, B., Dalby, R.N.  Are in vitro tests of nasal solutions predictive of in vivo deposition?  In: Dalby, R.N., Byron, P.R., and Farr, S. J., eds.  Respiratory Drug Delivery VII.  Raleigh, N.C.  Serentek Press, Inc. (2000), pp137-144.

 

Kapsali, T., Permutt, S., Laube B., Scichilone N, Togias, A.  The potent bronchoprotective effect of deep inspiration and its absence in asthma.  J.Appl. Physiol. 89:711-720, 2000.

 

Laube, B.L., Jashnani, R., Dalby, R.N., Zeitlin P.L.  Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.  Chest 118:1069-1076, 2000.

 

Lin, T-C., Breysse, P.N., Laube, B.L., Swift D.L.  Mouthpiece diameter affects deposition efficiency in cast models of the human oral airways.  J.Aerosol Med. 14:335-341, 2001.

 

Laube, B.L.  Treating diabetes with aerosolized insulin.  Chest 120:(Supplement) 99S-106S, 2001.

 

Flotte, T.R. and Laube, B.L.  Gene therapy in cystic fibrosis.  Chest 120:(Supplement) 124S-131S, 2001.

 

Suman, J., Laube, B.L., Lin, T-C., Guillaume, B., Dalby, R.N.  Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition.  Pharm. Res. 19:1-6, 2002.

 

Publications Next

615 N. Wolfe Street, Baltimore, MD 21205